Bottom line
Is PSIJX a good fund? The bottom line
PSIJX is the Class J share class of SmallCap Growth Fund I, an actively managed small-cap mutual fund from Principal.
It charges 1.14% — about $114 a year on every $10,000 invested, more expensive than 64% of small-cap funds we track.
It returned +11.5% over one year, +2.6% a year over five years, +10.7% a year over ten (as of Dec 31, 2025, per its prospectus).
With $2.5 billion in net assets and 1,220 holdings, its largest position is Principal Funds, Inc - Government Money Market Fund - Class R-6 (3.4%) and the top 10 make up 12.7% of the portfolio.
What stands out
- Broadly diversified (1,220 holdings)
What to watch
- 5-year return in the bottom quarter of its category
- 12b-1 marketing fee of 0.15% a year
Updated Nov 19, 2026
What PSIJX invests in
The Fund seeks long-term growth of capital.
Under normal circumstances, the Fund invests at least 80% of its net assets, plus any borrowings for investment purposes, in growth equity securities of companies with small market capitalizations. For this Fund, growth equity securities of companies with small market capitalizations are (i) those with market capitalizations within the range of companies comprising the Russell 2000 Index (as of January 30, 2026, this range was between $10.0 million and $38.2 billion) and (ii) included within at least one of the following growth indices: the MSCI All Country World IMI Growth Index, the S&P 1500 Growth Index, or the Russell 3000 Growth Index. The Fund is primarily actively managed by the sub-advisors. In addition, Principal Global Investors, LLC may invest up to 30% of the Funds assets using an index sampling strategy designed to match the performance of the Russell 2000 Growth Index.
From the fund's prospectus (filed Feb 27, 2026).
PSIJX performance
| 1 yr | 5 yr | 10 yr | |
|---|---|---|---|
| PSIJX | +11.5% | +2.6% | +10.7% |
| Small-Cap median | +7.6% | +7.0% | +9.2% |
Source: Fund prospectus, as of Dec 31, 2025
What PSIJX costs
On a $10,000 investment, PSIJX's 1.14% expense ratio costs about $114 a year. The prospectus estimates $1,407 in total costs over 10 years (assuming 5% annual returns). The median small-cap fund charges 0.99%.
PSIJX top 10 holdings
| # | Holding | % of fund |
|---|---|---|
| 1 | Principal Funds, Inc - Government Money Market Fund - Class R-6 | 3.43% |
| 2 | Guardant Health Inc | 1.35% |
| 3 | ESCO Technologies Inc | 1.14% |
| 4 | Oceaneering International Inc | 1.07% |
| 5 | BrightSpring Health Services Inc | 1.00% |
| 6 | Plexus Corp | 0.97% |
| 7 | Cogent Biosciences Inc | 0.96% |
| 8 | Enpro Inc | 0.93% |
| 9 | Travere Therapeutics Inc | 0.91% |
| 10 | Rush Street Interactive Inc | 0.91% |
Source: SEC Form N-PORT, period ended Jul 31, 2026
The top 10 make up 12.7% of the fund. See all top 25 holdings and asset mix →